Amphastar Pharmaceuticals
AMPH
AMPH
116 hedge funds and large institutions have $388M invested in Amphastar Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 42 increasing their positions, 36 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
2% less capital invested
Capital invested by funds: $397M → $388M (-$9.83M)
Holders
116
Holding in Top 10
–
Calls
$44K
Puts
–
Top Buyers
| 1 | +$4.91M | |
| 2 | +$4.29M | |
| 3 | +$1.4M | |
| 4 |
Morgan Stanley
New York
|
+$1.22M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.01M |
Top Sellers
| 1 | -$4.69M | |
| 2 | -$2.85M | |
| 3 | -$2.84M | |
| 4 |
BlackRock
New York
|
-$2.12M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$1.18M |